Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Inventory (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Change in Inventory for 14 consecutive years, with -$483000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 719.23% to -$483000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 2552.79% year-over-year, with the annual reading at $7.5 million for FY2025, 2552.79% up from the prior year.
  • Change in Inventory hit -$483000.0 in Q4 2025 for Corcept Therapeutics, down from $3.9 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.6 million in Q2 2025 to a low of -$1.1 million in Q3 2024.
  • Historically, Change in Inventory has averaged $63400.0 across 5 years, with a median of -$520500.0 in 2023.
  • Biggest five-year swings in Change in Inventory: tumbled 1053.49% in 2021 and later soared 464.75% in 2025.
  • Year by year, Change in Inventory stood at -$789000.0 in 2021, then soared by 84.16% to -$125000.0 in 2022, then tumbled by 163.2% to -$329000.0 in 2023, then soared by 123.71% to $78000.0 in 2024, then plummeted by 719.23% to -$483000.0 in 2025.
  • Business Quant data shows Change in Inventory for CORT at -$483000.0 in Q4 2025, $3.9 million in Q3 2025, and $4.6 million in Q2 2025.